Correlation Between Oxford Nanopore and Nurix Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Nurix Therapeutics, you can compare the effects of market volatilities on Oxford Nanopore and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Nurix Therapeutics.

Diversification Opportunities for Oxford Nanopore and Nurix Therapeutics

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Oxford and Nurix is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Oxford Nanopore and Nurix Therapeutics

Assuming the 90 days horizon Oxford Nanopore Technologies is expected to generate 1.64 times more return on investment than Nurix Therapeutics. However, Oxford Nanopore is 1.64 times more volatile than Nurix Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  181.00  in Oxford Nanopore Technologies on September 3, 2024 and sell it today you would earn a total of  27.00  from holding Oxford Nanopore Technologies or generate 14.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oxford Nanopore Technologies  vs.  Nurix Therapeutics

 Performance 
       Timeline  
Oxford Nanopore Tech 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Oxford Nanopore Technologies are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Oxford Nanopore reported solid returns over the last few months and may actually be approaching a breakup point.
Nurix Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Oxford Nanopore and Nurix Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oxford Nanopore and Nurix Therapeutics

The main advantage of trading using opposite Oxford Nanopore and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.
The idea behind Oxford Nanopore Technologies and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device